Objectives: This study aims to assess the impact of a virtual reality trainer in improving percutaneous renal access skills of urological trainees. Methods: A total of 36 urology trainees participated in this prospective study. Initially, they were taken through the exercise of gaining access to the lower pole calyceal system and introducing a guidewire down the ureter. Trainees’ performance was then assessed by virtual reality-derived parameters of the simulator at baseline and after 2 h of training. Results: Participants who underwent training with the simulator demonstrated significant improvement in several parameters compared to their baseline performance. There was a statistically significant correlation between total time to perform the procedure and time of radiation exposure, radiation dose and correct calyx puncture (p < 0.01). Trainees needed a mean of 15.8 min from skin puncture to correct guidewire placement into the pelvicalyceal system before and 6.49 min following training. Conclusions: We found percutaneous renal access skills of trainees improve significantly on a number of parameters as a result of training on the PERC Mentor TM VR simulator. Such simulated training has the potential to decrease the risks and complications associated with the early stages of the learning curve when training for percutaneous renal access in patients.

Keywords:
Virtual reality simulator, Percutaneous renal access, Urology trainees
1.
Masood J, Ismail M, El-Husseiny T, et al: ‘An interventional urology list’ – a novel concept for UK urological services. Ann R Coll Surg Engl 2011;93:27–30.
2.
Skolarikos A, Alivizatos G, Papatsoris A, Constantinides K, Zerbas A, Deliveliotis C: Ultrasound-guided percutaneous nephrostomy performed by urologists: 10-year experience. Urology 2006;68:495–499.
3.
Seymour NE: VR to OR: A review of the evidence that virtual reality simulation improves operating room performance. World J Surg 2008;32:182–188.
4.
Carter BN: The fruition of Halsted’s concept of surgical training. Surgery 1952;32:518–527.
5.
Matsumoto ED, Hamstra SJ, Radomski SB, Cusimano MD: A novel approach to endourology training. Training at the surgical skills centre. J Urol 2001;166:1261–1266.
6.
Knudsen BE, Matsumoto ED, Chew BH, et al: A randomised, controlled, prospective study validating the acquisition of percutaneous renal collecting system access skills using a computer based hybrid virtual reality surgical simulator: phase 1. J Urol 2006;176:2173–2178.
7.
Kim SC, Kuo RL, Lingeman JE: Percutaneous nephrolithotomy: an update. Curr Opin Urol 2003;13:235–241.
8.
De la Rosette J, Laguna MP, Rassweiler JJ, Conort P: Training in percutaneous nephrolithotomy – a critical review. Eur Urol 2008;54:994–1001.
9.
Wignall GR, Denstedt JD, Preminger GM, et al: Surgical simulation. A urological perspective. J Urol 2008;179:1690–1699.
10.
Gallagher AG, Ritter M, Champion H, Higgins G, Fried MP, Moses G, et al: Virtual reality simulation for the operating room. Proficiency based training as a paradigm shift in surgical skills training. Ann Surg 2005;341:364–372.
11.
Mishra S, Kurien A, Ganpule A, Muthu V, Sabnis R, Desai M: Percutaneous renal access training: content validation comparison between a live porcine and a virtual reality (VR) simulation model. BJU Int 2010;106:1753–1756.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.